96 related articles for article (PubMed ID: 3028965)
1. International experiences with ofloxacin, a new quinolone.
Mitsuhashi S
Infection; 1986; 14 Suppl 4():S223-5. PubMed ID: 3028965
[TBL] [Abstract][Full Text] [Related]
2. Antibacterial activity of ofloxacin and its mode of action.
Sato K; Inoue Y; Fujii T; Aoyama H; Mitsuhashi S
Infection; 1986; 14 Suppl 4():S226-30. PubMed ID: 3028966
[TBL] [Abstract][Full Text] [Related]
3. Antibacterial activity of ofloxacin and other 4-quinolone derivatives: in-vitro and in-vivo comparison.
Chantot JF; Bryskier A
J Antimicrob Chemother; 1985 Oct; 16(4):475-84. PubMed ID: 3864775
[TBL] [Abstract][Full Text] [Related]
4. Ofloxacin: bactericidal effect in an in vitro pharmacokinetic model.
Xerri L; Broggio R; Guerra L
Chemioterapia; 1986 Apr; 5(2):83-7. PubMed ID: 3085961
[TBL] [Abstract][Full Text] [Related]
5. [Clinical pharmacology of ofloxacin: a new chemotherapeutic agent belonging to the gyrase inhibitor group].
Verho M; Dagrosa EE; Malerczyk V
Infection; 1986; 14 Suppl 1():S47-53. PubMed ID: 3007366
[TBL] [Abstract][Full Text] [Related]
6. Ofloxacin: in vitro and in vivo activity.
Guerra L; Caro B; Erani E; Xerri L
Chemioterapia; 1987 Feb; 6(1):23-31. PubMed ID: 3470154
[TBL] [Abstract][Full Text] [Related]
7. Inhibition of DNA gyrase by optically active ofloxacin.
Imamura M; Shibamura S; Hayakawa I; Osada Y
Antimicrob Agents Chemother; 1987 Feb; 31(2):325-7. PubMed ID: 3032098
[TBL] [Abstract][Full Text] [Related]
8. Antagonism of wild-type and resistant Escherichia coli and its DNA gyrase by the tricyclic 4-quinolone analogs ofloxacin and S-25930 stereoisomers.
Wolfson JS; Hooper DC; Ng EY; Souza KS; McHugh GL; Swartz MN
Antimicrob Agents Chemother; 1987 Nov; 31(11):1861-3. PubMed ID: 2829717
[TBL] [Abstract][Full Text] [Related]
9. Chiral DNA gyrase inhibitors. 2. Asymmetric synthesis and biological activity of the enantiomers of 9-fluoro-3-methyl-10-(4-methyl-1-piperazinyl)-7-oxo-2,3-dihydro-7H- pyrido[1,2,3-de]-1,4-benzoxazine-6-carboxylic acid (ofloxacin).
Mitscher LA; Sharma PN; Chu DT; Shen LL; Pernet AG
J Med Chem; 1987 Dec; 30(12):2283-6. PubMed ID: 2824776
[TBL] [Abstract][Full Text] [Related]
10. Ofloxacin. A review of its antibacterial activity, pharmacokinetic properties and therapeutic use.
Monk JP; Campoli-Richards DM
Drugs; 1987 Apr; 33(4):346-91. PubMed ID: 3297617
[TBL] [Abstract][Full Text] [Related]
11. [In vitro and in vivo antibacterial activities of pazufloxacin mesilate, a new injectable quinolone].
Nomura N; Mitsuyama J; Furuta Y; Yamada H; Nakata M; Fukuda T; Yamada H; Takahata M; Minami S
Jpn J Antibiot; 2002 Aug; 55(4):412-39. PubMed ID: 12378871
[TBL] [Abstract][Full Text] [Related]
12. [Dependence of the bactericidal activity and mutant selection of 4-quinolones on their serum concentration levels].
Bauernfeind A; Petermüller C; Heinrich B; Gablac R
Infection; 1986; 14 Suppl 1():S26-30. PubMed ID: 3082765
[TBL] [Abstract][Full Text] [Related]
13. Synthesis and bacterial DNA gyrase inhibitory properties of a spirocyclopropylquinolone derivative.
Wentland MP; Perni RB; Dorff PH; Rake JB
J Med Chem; 1988 Sep; 31(9):1694-7. PubMed ID: 2842501
[TBL] [Abstract][Full Text] [Related]
14. [In vitro antibacterial activity and pharmacokinetics of ofloxacin in chronic respiratory tract infections].
Sugimoto Y; Matsumoto Y; Hitsuda Y; Yamamoto Y; Ishitobi K; Sasaki T
Jpn J Antibiot; 1987 Feb; 40(2):325-30. PubMed ID: 3474429
[TBL] [Abstract][Full Text] [Related]
15. Comparison of the in vitro activity of ofloxacin and gentamicin against isolates from hospitalised patients.
Adeyemi-Doro FA; Rotowa NA
Infection; 1986; 14 Suppl 4():S240-2. PubMed ID: 3469154
[TBL] [Abstract][Full Text] [Related]
16. [Gyrase inhibitor].
Forth W
Klin Wochenschr; 1985 Oct; 63(19):1036-9. PubMed ID: 2999503
[No Abstract] [Full Text] [Related]
17. [Pharmacokinetic and clinical study of ofloxacin, a new antibacterial effective agent].
Aderhold L; Frenkel G
Dtsch Z Mund Kiefer Gesichtschir; 1985; 9(5):394-7. PubMed ID: 3868471
[No Abstract] [Full Text] [Related]
18. Comparative in vitro activity of three new quinolone antibiotics against recent clinical isolates.
Forsgren A
Scand J Infect Dis; 1985; 17(1):91-4. PubMed ID: 3158070
[TBL] [Abstract][Full Text] [Related]
19. In vitro and in vivo antibacterial activity of T-3912, a novel non-fluorinated topical quinolone.
Yamakawa T; Mitsuyama J; Hayashi K
J Antimicrob Chemother; 2002 Mar; 49(3):455-65. PubMed ID: 11864945
[TBL] [Abstract][Full Text] [Related]
20. In vitro study of the antibacterial activity of ofloxacin against recent clinical isolates.
Varoli O; Ferri M
Drugs Exp Clin Res; 1987; 13(4):209-12. PubMed ID: 3476290
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
